Meghan Trainor Opens Up About GLP-1 Medication and Weight Loss Journey

Meghan Trainor, the 31-year-old singer and podcast host, has publicly shared her experience with GLP-1 medications, specifically Mounjaro, as part of her weight loss and health journey. In an April 2025 episode of her podcast *Workin’ On It* with husband Daryl Sabara, Trainor revealed that she and her partner both began taking the drug after researching options and consulting their doctors. “We did 75 Hard after Riley was born and, man, did we crush,” she said, referencing the 75-day fitness challenge. “Then, we heard more and more of our friends—and even our doctors—were on Mounjaro, and Ozempic.”

Why Mounjaro? Understanding the Drug

Mounjaro (tirzepatide) is a GLP-1 receptor agonist originally approved for managing type 2 diabetes but has gained popularity as a weight-loss treatment. Trainor emphasized that she chose Mounjaro over other options due to its “less side effects” profile. “I could do that [lose weight on my own], but when I asked my doctor, I was like, ‘Tell me everything.’ I did the research, and I felt safe,” she explained. The couple started on the lowest possible dose, combining the medication with exercise and balanced meals to avoid muscle loss.

Trainor also highlighted the drug’s impact on her hunger levels. “We noticed that we were less hungry,” she said, adding that the medication “helped us stay in the gym, work out, and eat right.” By April 2026, she reported losing 53 pounds since starting the treatment in February 2026, calling the results “a very significant positive change” in her health and quality of life.

Public Health Trends and GLP-1 Use

The use of GLP-1 medications for weight loss has surged in recent years, with celebrities and public figures increasingly open about their experiences. Trainor’s candidness aligns with a broader cultural shift toward discussing health strategies, though experts caution that these drugs are not a quick fix. “They’re part of a comprehensive approach that includes diet, exercise, and medical supervision,” said Dr. Sarah Johnson, a metabolic health specialist.

Despite the popularity, concerns about long-term side effects and accessibility remain. Mounjaro requires a prescription and can be costly, with monthly expenses averaging $900–$1,200. Trainor’s emphasis on consulting her doctor underscores the importance of personalized medical guidance.

Key Takeaways

• Meghan Trainor and Daryl Sabara both use Mounjaro as part of their health journey, citing reduced hunger and improved fitness habits.
• Mounjaro, a GLP-1 medication, is used for diabetes management and weight loss, with Trainor noting its “less side effects” profile.
• Trainor lost 53 pounds since starting the drug in February 2026, calling the results “life-changing.”
• Health experts stress that GLP-1 medications should be paired with diet, exercise, and medical oversight.

As more individuals share their experiences with GLP-1 drugs, the conversation around weight management continues to evolve. Trainor’s openness highlights both the potential benefits and the need for informed, responsible use of these treatments.